abstract |
The invention relates to pharmaceutical compositions and methods of producing bacterial host surface-expressed heterologous polypeptides useful in the preparation of vaccines, and particularly oral vaccines for prophylaxis of diseases associated with cholera, human immunodeficiency virus, influenza virus, and rickettsial infections. |